226 related articles for article (PubMed ID: 16403823)
1. Improvement of cardiac performance and cardiovascular risk factors in children with GH deficiency after two years of GH replacement therapy: an observational, open, prospective, case-control study.
Salerno M; Esposito V; Farina V; Radetti G; Umbaldo A; Capalbo D; Spinelli L; Muzzica S; Lombardi G; Colao A
J Clin Endocrinol Metab; 2006 Apr; 91(4):1288-95. PubMed ID: 16403823
[TBL] [Abstract][Full Text] [Related]
2. Left ventricular mass and function in children with GH deficiency before and during 12 months GH replacement therapy.
Salerno M; Esposito V; Spinelli L; Di Somma C; Farina V; Muzzica S; de Horatio LT; Lombardi G; Colao A
Clin Endocrinol (Oxf); 2004 May; 60(5):630-6. PubMed ID: 15104568
[TBL] [Abstract][Full Text] [Related]
3. Does a gender-related effect of growth hormone (GH) replacement exist on cardiovascular risk factors, cardiac morphology, and performance and atherosclerosis? Results of a two-year open, prospective study in young adult men and women with severe GH deficiency.
Colao A; Di Somma C; Cuocolo A; Spinelli L; Acampa W; Spiezia S; Rota F; Savanelli MC; Lombardi G
J Clin Endocrinol Metab; 2005 Sep; 90(9):5146-55. PubMed ID: 15985481
[TBL] [Abstract][Full Text] [Related]
4. The cardiovascular risk of adult GH deficiency (GHD) improved after GH replacement and worsened in untreated GHD: a 12-month prospective study.
Colao A; di Somma C; Pivonello R; Cuocolo A; Spinelli L; Bonaduce D; Salvatore M; Lombardi G
J Clin Endocrinol Metab; 2002 Mar; 87(3):1088-93. PubMed ID: 11889170
[TBL] [Abstract][Full Text] [Related]
5. Three weekly injections (TWI) of low-dose growth hormone (GH) restore low normal circulating IGF-I concentrations and reverse cardiac abnormalities associated with adult onset GH deficiency (GHD).
Pincelli AI; Bragato R; Scacchi M; Branzi G; Osculati G; Viarengo R; Leonetti G; Cavagnini F
J Endocrinol Invest; 2003 May; 26(5):420-8. PubMed ID: 12906369
[TBL] [Abstract][Full Text] [Related]
6. The cardiovascular risk of GH-deficient adolescents.
Colao A; Di Somma C; Salerno M; Spinelli L; Orio F; Lombardi G
J Clin Endocrinol Metab; 2002 Aug; 87(8):3650-5. PubMed ID: 12161490
[TBL] [Abstract][Full Text] [Related]
7. Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency.
Colao A; di Somma C; Cuocolo A; Spinelli L; Tedesco N; Pivonello R; Bonaduce D; Salvatore M; Lombardi G
J Clin Endocrinol Metab; 2001 May; 86(5):1874-81. PubMed ID: 11344175
[TBL] [Abstract][Full Text] [Related]
8. Serum homocysteine concentrations in children with growth hormone (GH) deficiency before and after 12 months GH replacement.
Esposito V; Di Biase S; Lettiero T; Labella D; Simeone R; Salerno M
Clin Endocrinol (Oxf); 2004 Nov; 61(5):607-11. PubMed ID: 15521964
[TBL] [Abstract][Full Text] [Related]
9. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents.
Lanes R; Gunczler P; Lopez E; Esaa S; Villaroel O; Revel-Chion R
J Clin Endocrinol Metab; 2001 Mar; 86(3):1061-5. PubMed ID: 11238486
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of left ventricular mass and function, lipid profile, and insulin resistance in Egyptian children with growth hormone deficiency: A single-center prospective case-control study.
Metwalley KA; Farghaly HS; Abd El-Hafeez HA
Indian J Endocrinol Metab; 2013 Sep; 17(5):876-82. PubMed ID: 24083170
[TBL] [Abstract][Full Text] [Related]
11. Cardiac mass and function, carotid artery intima media thickness, homocysteine and lipoprotein levels in children and adolescents with growth hormone deficiency.
Szczepańiska Kostro J; Tołwińska J; Urban M; Gardziejczyk M; Głowińska B
J Pediatr Endocrinol Metab; 2004 Oct; 17(10):1405-13. PubMed ID: 15526719
[TBL] [Abstract][Full Text] [Related]
12. Subtle alterations of cardiac performance in children with growth hormone deficiency: results of a two-year prospective, case-control study.
Capalbo D; Lo Vecchio A; Farina V; Spinelli L; Palladino A; Tiano C; Lettiero T; Lombardi G; Colao A; Salerno M
J Clin Endocrinol Metab; 2009 Sep; 94(9):3347-55. PubMed ID: 19584193
[TBL] [Abstract][Full Text] [Related]
13. Metabolic parameters and adipokine profile during GH replacement therapy in children with GH deficiency.
Ciresi A; Amato MC; Criscimanna A; Mattina A; Vetro C; Galluzzo A; D'Acquisto G; Giordano C
Eur J Endocrinol; 2007 Mar; 156(3):353-60. PubMed ID: 17322495
[TBL] [Abstract][Full Text] [Related]
14. Cross-sectional and prospective study of the effects of GH therapy on metabolic panel in children with GH deficiency.
Ramistella V; Wasniewska M; Arasi S; Catena M; Velletri MR; Corica D; Santucci S; De Luca F
Pediatr Med Chir; 2014 Dec; 36(5-6):104. PubMed ID: 25669895
[TBL] [Abstract][Full Text] [Related]
15. Effects of one year of recombinant human growth hormone (GH) therapy on cardiac mass and function in children with classical GH deficiency.
Shulman DI; Root AW; Diamond FB; Bercu BB; Martinez R; Boucek RJ
J Clin Endocrinol Metab; 2003 Sep; 88(9):4095-9. PubMed ID: 12970269
[TBL] [Abstract][Full Text] [Related]
16. Impaired cardiac performance in elderly patients with growth hormone deficiency.
Colao A; Cuocolo A; Di Somma C; Cerbone G; Della Morte AM; Nicolai E; Lucci R; Salvatore M; Lombardi G
J Clin Endocrinol Metab; 1999 Nov; 84(11):3950-5. PubMed ID: 10566633
[TBL] [Abstract][Full Text] [Related]
17. Improvement in cardiac systolic function and reduced prevalence of metabolic syndrome after two years of growth hormone (GH) treatment in GH-deficient adult survivors of childhood-onset acute lymphoblastic leukemia.
Follin C; Thilén U; Ahrén B; Erfurth EM
J Clin Endocrinol Metab; 2006 May; 91(5):1872-5. PubMed ID: 16522695
[TBL] [Abstract][Full Text] [Related]
18. The natural history of partial growth hormone deficiency in adults: a prospective study on the cardiovascular risk and atherosclerosis.
Colao A; Di Somma C; Spiezia S; Rota F; Pivonello R; Savastano S; Lombardi G
J Clin Endocrinol Metab; 2006 Jun; 91(6):2191-200. PubMed ID: 16537686
[TBL] [Abstract][Full Text] [Related]
19. [Left ventricular mass and function in growth hormone deficient children and adolescents before and after one year of recombinant human growth hormone (GH) replacement therapy].
Szczepańska Kostro J; Tołwińska J; Urban M; Głowińska B
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):75-80. PubMed ID: 15504309
[TBL] [Abstract][Full Text] [Related]
20. The influence of growth hormone (GH) therapy on cardiac performance in patients with childhood onset GH deficiency.
Minczykowski A; Gryczynska M; Ziemnicka K; Czepczynski R; Sowinski J; Wysocki H
Growth Horm IGF Res; 2005 Apr; 15(2):156-64. PubMed ID: 15809020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
